
浏览全部资源
扫码关注微信
1.400038 重庆,陆军军医大学(第三军医大学)第一附属医院麻醉科
2.400038 重庆,陆军军医大学(第三军医大学)药学与检验医学系生药学与中药学教研室
[顾健腾,E-mail:gjt1976@163.com GU Jianteng, E-mail: gjt1976@163.com
收稿:2023-10-18,
修回:2023-12-08,
纸质出版:2024-01-15
移动端阅览
黎洁钰, 秦志刚, 薛正威, 等. 右美托咪定对急性肾损伤继发肺损伤的修复功用[J]. 陆军军医大学学报, 2024,46(1):66-72.
Jieyu LI, Zhigang QIN, Zhengwei XUE, et al. Reparative role of dexmedetomidine in lung injury secondary to acute kidney injury[J]. Journal of Army Medical University, 2024, 46(1): 66-72.
黎洁钰, 秦志刚, 薛正威, 等. 右美托咪定对急性肾损伤继发肺损伤的修复功用[J]. 陆军军医大学学报, 2024,46(1):66-72. DOI: 10.16016/j.2097-0927.202310070.
Jieyu LI, Zhigang QIN, Zhengwei XUE, et al. Reparative role of dexmedetomidine in lung injury secondary to acute kidney injury[J]. Journal of Army Medical University, 2024, 46(1): 66-72. DOI: 10.16016/j.2097-0927.202310070.
目的
2
探讨右美托咪定(Dexmedetomidine,Dex)对急性肾损伤(acute kidney injury,AKI)继发肺损伤的修复功用。
方法
2
将75只6~8周龄健康SPF级雄性C57BL/6J小鼠(体质量20~22 g)随机分为:假手术(Sham)组,常规行开腹关腹手术;肾缺血再灌注(RIR)组,双侧肾蒂夹闭50 min后再灌注;Dex预处理(Dex + RIR)组,双侧肾蒂夹闭前15 min经腹腔注射Dex(25 μg/kg)。各组于造模后24、48、72、96、120 h(
n
=5),收集肺组织、肺泡灌洗液(bronchoalveolar lavage fluid,BALF)、颈动脉血。观察并比较各组不同时间点肺组织损伤程度及修复情况、动脉血氧分压(PaO
2
)、肺泡灌洗液转化生长因子β1(transforming growth factor β1
TGF-β1)和结缔组织生长因子(connective tissue growth factor
CTGF)含量。反转录实时定量聚合酶链式反应(quantitative real-time RT-PCR,RT-qPCR)检测肺组织白细胞介素-6(
IL-6
)、肺表面活性蛋白C(surfactant protein C,
SP-C
)转录水平。
结果
2
与Sham组比较,AKI后48 h内,RIR组和Dex+RIR组肺损伤评分升高、PaO
2
降低,但Dex+RIR组肺损伤评分及PaO
2
水平均优于RIR组;AKI后96 h内RIR组肺损伤评分维持高水平,PaO
2
维持低水平,而Dex+RIR组肺损伤评分和PaO
2
于48 h后出现持续好转。AKI后RIR组肺泡灌洗液TGF-β1和CTGF以及肺组织
IL-6
转录水平呈现出由高水平向低水平变化的趋势,但均显著高于Sham组(
P
<0.05),Dex干预使24~120 h时间点TGF-β1显著降低(
P
<
0.01),24~72 h
IL-6
转录水平显著降低(
P
<
0.05),而CTGF呈上升趋势并于48~96 h维持较高水平;AKI后RIR组
SP-C
转录水平在24 h显著上调(与Sham组比较,
P
<
0.001),48~120 h大幅下降至低水平(与RIR组24 h比较,
P
<
0.05),而Dex可改善此种AKI所致的
SP-C
转录抑制现象。
结论
2
Dex可改善急性肾损伤继发肺损伤后肺换气功能,并将肺损伤修复时间窗从96~120 h提前至48~72 h。
Objective
2
To investigate the reparative role of dexmedetomidine (Dex) in lung injury secondary to acute kidney injury (AKI).
Methods
2
A total of 75 healthy SPF male C57BL/6J mice (6-8 weeks old
weighing 20-22 g) were randomly divided into Sham group (standard laparotomy)
renal ischemia reperfusion group (RIR
clamping of bilateral renal pedicles for 50 min followed by repe
rfusion)
and Dex pretreatment group (Dex+RIR
intraperitoneal injection of 25 μg/kg Dex 15 min before bilateral renal pedicle clamping). Lung tissues
bronchoalveolar lavage fluid (BALF)
and carotid arterial blood samples were collected from 5 mice in each group at 24
48
72
96
and 120 h after modeling. Lung injury and repair
arterial blood partial pressure of oxygen (PaO
2
)
and BALF contents of transforming growth factor β1 (TGF-β1) and connective tissue growth factor (CTGF) were observed and detected for comparison in the groups at different time points. Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was used to detect the transcript levels of interleukin-6(
IL-6
) and lung surfactant protein C (
SP-C
).
Results
2
Within 48 h after AKI
lung injury score was increased and PaO
2
was decreased in the RIR group and Dex+RIR group than the Sham group
but Dex pretreatment reversed the lung injury score and PaO
2
level when compared with the RIR group. The lung injury score was still in a high level and PaO
2
stayed low in the RIR group within 96 h after AKI
whereas the 2 indicators in the Dex+RIR group showed a sustained improvement in 48 h after injury. After AKI
the BALF contents of TGF-β1 and CTGF and mRNA level of
IL-6
in lung tissue showed a decreasing trend from high level to low level in the RIR group
but all of them were significantly higher than those in the Sham group (
P
<
0.05)
while Dex intervention resulted in an obvious decrease of TGF-β1 at 24-120 h (
P
<
0.01) and a notable reduction of
IL-6
mRNA level at 24-72 h (
P
<
0.05)
whereas a raising trend and maintenance of high level in CTGF at 48-96 h. After AKI
the mRNA level of
SP-C
in the RIR group were up-regulated at 24 h (
P
<
0.001
when compared to the Sham group) and then dimin
ished to a low level at 48-120 h (
P
<
0.05
when compared to the RIR group at 24 h)
however Dex pretreatment could alleviate the transcriptional repression of
SP-C
caused by AKI.
Conclusion
2
Dex can ameliorate pulmonary ventilation after lung injury secondary to AKI
and then advance the time for lung repair from 96-120 h to 48-72 h.
RONCO C, BELLOMO R, KELLUM J A. Acute kidney injury[J]. Lancet, 2019, 394(10212): 1949-1964. DOI: 10.1016/s0140-6736(19)32563-2.
AL-JAGHBEER M, DEALMEIDA D, BILDERBACK A, et al . Clinical decision support for in-hospital AKI[J ] . J Am Soc Nephrol, 2018, 29(2): 654-660. DOI: 10.1681/asn.2017070765.
HOSTE E A J, BAGSHAW S M, BELLOMO R, et al . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study[J ] . Intensive Care Med, 2015, 41(8): 1411-1423. DOI: 10.1007/s00134-015-3 934-7.
HOSTE E A J, CLERMONT G, KERSTEN A, et al . RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis[J ] . Crit Care, 2006, 10(3): R73. DOI: 10.1186/cc4915.
BONVENTRE J V, YANG L. Cellular pathophysiology of ischemic acute kidney injury[J]. J Clin Investig, 2011, 121(11): 4210-4221. DOI: 10.1172/jci45161.
ZUK A, BONVENTRE J V. Acute kidney injury[J]. Annu Rev Med, 2016, 67: 293-307. DOI: 10.1146/annurev-med-050214-013407.
PEERAPORNRATANA S, MANRIQUE-CABALLERO C L, GÓMEZ H, et al . Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment[J ] . Kidney Int, 2019, 96(5): 1083-1099. DOI: 10.1016/j.kint.2019.05.026.
FAUBEL S, EDELSTEIN C L. Mechanisms and mediators of lung injury after acute kidney injury[J]. Nat Rev Nephrol, 2016, 12(1): 48-60. DOI: 10.1038/nrneph.2015.158.
DEMIRI M, ANTUNES T, FLETC HER D, et al . Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis[J ] . Br J Anaesth, 2019, 123(6): 795-807. DOI: 10.1016/j.bja.2019.07.029.
ZHAO S K, WU W Z, LIN X Z, et al . Protective effects of dexmedetomidine in vital organ injury: crucial roles of autophagy[J ] . Cell Mol Biol Lett, 2022, 27(1): 34. DOI: 10.1186/s11658-022-00335-7.
LI J J, CHEN Q, HE X H, et al . Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α 2 AR/PI3K/Akt pathway[J ] . J Transl Med, 2018, 16(1): 78. DOI: 10.1186/s12967-018-1455-1..
GU J, CHEN J, XIA P, et al . Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice[J ] . Acta Anaesthesiol Scand, 2011, 55(10): 1272-1278. DOI: 10.1111/j.1399-6576.2011.02526.x.
MENG X Y, LU Q Y, ZHANG J F, et al . A novel animal model of primary blast lung injury and its pathological changes in mice[J ] . J Trauma Acute Care Surg, 2022, 93(4): 530-537. DOI: 10.1097/ta.0000000000003571.
ALGE J, DOLAN K, ANGELO J, et al . Two to tango: kidney-lung interaction in acute kidney injury and acute respiratory distress syndrome[J ] . Front Pediatr, 2021, 9: 744110. DOI: 10.3389/fped.2021.744110.
CHEN D W, JIANG L L, LI J, et al . Interaction of acute respiratory failure and acute kidney injury on in-hospital mortality of patients with acute exacerbation COPD[J ] . Int J Chron Obstruct Pulmon Dis, 2021, 16: 3309-3316. DOI: 10.2147/copd.s334219.
LIEUWE D J, BOS, PHD, et al . Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes[J ] . Lancet, 2022, 400(10358): 1145-1156. DOI: 10.1016/S0140-6736(22)01485-4.
CHEN Q, YI B, MA J B, et al . α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury[J ] . Oncotarget, 2016, 7(35): 55990-56001. DOI: 10.18632/oncotarget.10809.
CHEN Q, QIN Z G, SUN Y B, et al . Dexmedetomidine activates Akt, STAT6 and IRF 4 modulating cytoprotection and macrophage anti-inflammatory phenotype against acute lung injury in vivo and in vitro [J ] . J Inflamm Res, 2022, 15: 2707-2720. DOI: 10.2147/JIR.S357012..
PENG D, FU M, WANG M, et al . Targeting TGF-β signal transduction for fibrosis and cancer therapy[J ] . Mol Cancer, 2022, 21(1): 104. DOI: 10.1186/s12943-022-01569-x.
SAITO A, HORIE M, NAGASE T. TGF-β signaling in lung health and disease[J]. Int J Mol Sci, 2018, 19(8): E2460. DOI: 10.3390/ijms19082460.
SUN J, ZHANG H, LIU D, et al. CTGF promotes the repair and regeneration of alveoli after acute lung injury by promoting the proliferation of subpopulation of AEC2s[J ] . Respir Res, 2023, 24(1): 227. DOI: 10.1186/s12931-023-02512-4.
NOLTE M, MARGADANT C. Controlling immunity and in-flammation through integrin-dependent regulation of TGF-β[J]. Trends Cell Biol, 2020, 30(1): 49-59. DOI:10.1016/j.tcb.2019.10.002.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621